Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neuroton is a Vitamin B complex formulation, primarily manufactured by Amoun Pharmaceutical Co., which typically contains thiamine (B1), pyridoxine (B6), and cyanocobalamin (B12). In the context of clinical research led by Ain Shams University, a version including folic acid (B9) is being evaluated for its analgesic efficacy in postoperative pain management, specifically for obstetric patients undergoing Cesarean sections. The drug is utilized as an adjuvant in multimodal analgesia to enhance the effects of standard treatments like paracetamol and NSAIDs while potentially reducing opioid requirements. Its mechanism of action involves the neurotropic properties of B vitamins, which support nerve regeneration and modulate pain signaling pathways by enhancing inhibitory neurotransmission (e.g., GABAergic and serotonergic systems) and stabilizing neuronal membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neuroton (Ain Shams University).